-+ 0.00%
-+ 0.00%
-+ 0.00%

RBC Capital Reinstates Outperform on Repligen, Announces $160 Price Target

Benzinga·05/15/2026 14:14:53
Listen to the news
RBC Capital analyst Dan Leonard reinstates Repligen (NASDAQ:RGEN) with a Outperform and announces $160 price target.